First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF.
First granted example of novel FDA trial design under Expedited Access Pathway for premarket approval: BeAT-HF. Am Heart J. 2018 10; 204:139-150.